Edition:
United Kingdom

Adaptimmune Therapeutics PLC (ADAP.OQ)

ADAP.OQ on NASDAQ Stock Exchange Global Select Market

11.89USD
9:00pm BST
Change (% chg)

$0.18 (+1.54%)
Prev Close
$11.71
Open
$11.75
Day's High
$12.06
Day's Low
$11.71
Volume
59,827
Avg. Vol
95,490
52-wk High
$14.62
52-wk Low
$6.60

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.06 December 24 Sep 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 2 2 2
(2) OUTPERFORM 4 4 4 3
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 1 1 1 1
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.00 2.12 2.12 2.14

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 8 33.03 52.00 20.72 3.46
Quarter Ending Dec-18 8 6.22 20.00 0.00 3.46
Year Ending Dec-18 8 56.41 73.00 37.96 28.13
Year Ending Dec-19 8 24.75 65.00 0.00 18.34
Earnings (per share)
Quarter Ending Sep-18 6 -0.06 0.26 -0.28 -0.28
Quarter Ending Dec-18 6 -0.35 -0.25 -0.50 -0.29
Year Ending Dec-18 6 -1.01 -0.68 -1.27 -0.99
Year Ending Dec-19 6 -1.24 -1.02 -1.56 -1.38

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-18 8.71 9.04 0.33 3.77
Quarter Ending Mar-18 9.10 8.20 0.91 9.96
Quarter Ending Dec-17 8.56 4.27 4.29 50.10
Quarter Ending Sep-17 6.26 27.18 20.93 334.54
Quarter Ending Jun-17 5.40 3.52 1.88 34.80
Earnings (per share)
Quarter Ending Jun-18 -0.27 -0.48 0.21 -75.63
Quarter Ending Mar-18 -0.24 -0.22 0.02 -8.98
Quarter Ending Dec-17 -0.23 -0.30 0.07 -31.41
Quarter Ending Sep-17 -0.23 -0.01 0.22 -96.03
Quarter Ending Jun-17 -0.25 -0.24 0.01 -2.72

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 33.03 32.03 32.03 30.04 3.46
Quarter Ending Dec-18 6.22 6.68 6.68 6.87 3.46
Year Ending Dec-18 56.41 55.87 55.84 53.81 28.13
Year Ending Dec-19 24.75 26.57 26.57 23.29 18.34
Earnings (per share)
Quarter Ending Sep-18 -0.06 -0.06 -0.06 -0.01 -0.28
Quarter Ending Dec-18 -0.35 -0.35 -0.35 -0.30 -0.29
Year Ending Dec-18 -1.01 -1.01 -1.01 -0.81 -0.99
Year Ending Dec-19 -1.24 -1.24 -1.24 -1.21 -1.38

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-18 0 0 0 0
Quarter Ending Dec-18 0 0 0 0
Year Ending Dec-18 0 0 1 0
Year Ending Dec-19 0 0 0 0
Earnings
Quarter Ending Sep-18 0 0 0 0
Quarter Ending Dec-18 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 0